Pavel Hoffmann

     

    Publications 2018

    Bethke A, Shanmuganathan L, Andersen GØ, Eritsland J, Swanson D, Kløw NE, Hoffmann P (2018)
    Microvascular perfusion in infarcted and remote myocardium after successful primary PCI: angiographic and CMR findings
    Eur Radiol, 29 (2), 941-950
    DOI 10.1007/s00330-018-5588-7, PubMed 29980929

    Bethke A, Shanmuganathan L, Shetelig C, Swanson D, Andersen GØ, Eritsland J, Kløw NE, Hoffmann P (2018)
    MR findings of microvascular perfusion in infarcted and remote myocardium early after successful primary PCI
    PLoS One, 13 (11), e0206723
    DOI 10.1371/journal.pone.0206723, PubMed 30412607

    Heck SL, Gulati G, Hoffmann P, von Knobelsdorff-Brenkenhoff F, Storås TH, Ree AH, Gravdehaug B, Røsjø H, Steine K, Geisler J, Schulz-Menger J, Omland T (2018)
    Effect of candesartan and metoprolol on myocardial tissue composition during anthracycline treatment: the PRADA trial
    Eur Heart J Cardiovasc Imaging, 19 (5), 544-552
    DOI 10.1093/ehjci/jex159, PubMed 29106497

    Hoffmann P, Al-Ani A, von Lueder T, Hoffmann J, Majak P, Hagen O, Loose H, Kløw NE, Opdahl A (2018)
    Access site complications after transfemoral aortic valve implantation - a comparison of Manta and ProGlide
    CVIR Endovasc, 1 (1), 20
    DOI 10.1186/s42155-018-0026-0, PubMed 30652151

    Orrem HL, Shetelig C, Ueland T, Limalanathan S, Nilsson PH, Husebye T, Aukrust P, Seljeflot I, Hoffmann P, Eritsland J, Mollnes TE, Andersen GØ, Yndestad A (2018)
    Soluble IL-1 receptor 2 is associated with left ventricular remodelling in patients with ST-elevation myocardial infarction
    Int J Cardiol, 268, 187-192
    DOI 10.1016/j.ijcard.2018.05.032, PubMed 29853279

    Shetelig C, Limalanathan S, Hoffmann P, Seljeflot I, Gran JM, Eritsland J, Andersen GØ (2018)
    Association of IL-8 With Infarct Size and Clinical Outcomes in Patients With STEMI
    J Am Coll Cardiol, 72 (2), 187-198
    DOI 10.1016/j.jacc.2018.04.053, PubMed 29976293

    Publications 2017

    Gulati G, Heck SL, Røsjø H, Ree AH, Hoffmann P, Hagve TA, Norseth J, Gravdehaug B, Steine K, Geisler J, Omland T (2017)
    Neurohormonal Blockade and Circulating Cardiovascular Biomarkers During Anthracycline Therapy in Breast Cancer Patients: Results From the PRADA (Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy) Study
    J Am Heart Assoc, 6 (11)
    DOI 10.1161/JAHA.117.006513, PubMed 29118031

    Ritschel V, Shetelig C, Seljeflot I, Limalanathan S, Hoffmann P, Halvorsen S, Arnesen H, Eritsland J, Andersen GØ (2017)
    Evaluation of circulating levels of CCN2/connective tissue growth factor in patients with ST-elevation myocardial infarction
    Sci Rep, 7 (1), 11945
    DOI 10.1038/s41598-017-12372-w, PubMed 28931920

    Sanders MF, van Doormaal PJ, Beeftink MMA, Bots ML, Fadl Elmula FEM, Habets J, Hammer F, Hoffmann P, Jacobs L, Mark PB, Persu A, Renkin J, Roditi G, Spiering W, Staessen JA, Taylor AH, Verloop WL, Vink EE, Vonken EJ, Voskuil M, Leiner T, Blankestijn PJ, European Network COordinating research on Renal Denervation (ENCOReD) Consortium (2017)
    Renal artery and parenchymal changes after renal denervation: assessment by magnetic resonance angiography
    Eur Radiol, 27 (9), 3934-3941
    DOI 10.1007/s00330-017-4770-7, PubMed 28271154

    Shetelig C, Limalanathan S, Eritsland J, Hoffmann P, Seljeflot I, Gran JM, Aukrust P, Ueland T, Andersen GØ (2017)
    Osteoprotegerin levels in ST-elevation myocardial infarction: Temporal profile and association with myocardial injury and left ventricular function
    PLoS One, 12 (3), e0173034
    DOI 10.1371/journal.pone.0173034, PubMed 28253327

    Publications 2016

    Engblom H, Heiberg E, Erlinge D, Jensen SE, Nordrehaug JE, Dubois-Randé JL, Halvorsen S, Hoffmann P, Koul S, Carlsson M, Atar D, Arheden H (2016)
    Sample Size in Clinical Cardioprotection Trials Using Myocardial Salvage Index, Infarct Size, or Biochemical Markers as Endpoint
    J Am Heart Assoc, 5 (3), e002708
    DOI 10.1161/JAHA.115.002708, PubMed 26961520

    Engblom H, Tufvesson J, Jablonowski R, Carlsson M, Aletras AH, Hoffmann P, Jacquier A, Kober F, Metzler B, Erlinge D, Atar D, Arheden H, Heiberg E (2016)
    A new automatic algorithm for quantification of myocardial infarction imaged by late gadolinium enhancement cardiovascular magnetic resonance: experimental validation and comparison to expert delineations in multi-center, multi-vendor patient data
    J Cardiovasc Magn Reson, 18 (1), 27
    DOI 10.1186/s12968-016-0242-5, PubMed 27145749

    Gulati G, Heck SL, Ree AH, Hoffmann P, Schulz-Menger J, Fagerland MW, Gravdehaug B, von Knobelsdorff-Brenkenhoff F, Bratland Å, Storås TH, Hagve TA, Røsjø H, Steine K, Geisler J, Omland T (2016)
    Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol
    Eur Heart J, 37 (21), 1671-80
    DOI 10.1093/eurheartj/ehw022, PubMed 26903532

    Nordlund D, Heiberg E, Carlsson M, Fründ ET, Hoffmann P, Koul S, Atar D, Aletras AH, Erlinge D, Engblom H, Arheden H (2016)
    Extent of Myocardium at Risk for Left Anterior Descending Artery, Right Coronary Artery, and Left Circumflex Artery Occlusion Depicted by Contrast-Enhanced Steady State Free Precession and T2-Weighted Short Tau Inversion Recovery Magnetic Resonance Imaging
    Circ Cardiovasc Imaging, 9 (7)
    DOI 10.1161/CIRCIMAGING.115.004376, PubMed 27412659

    Nordlund D, Klug G, Heiberg E, Koul S, Larsen TH, Hoffmann P, Metzler B, Erlinge D, Atar D, Aletras AH, Carlsson M, Engblom H, Arheden H (2016)
    Multi-vendor, multicentre comparison of contrast-enhanced SSFP and T2-STIR CMR for determining myocardium at risk in ST-elevation myocardial infarction
    Eur Heart J Cardiovasc Imaging, 17 (7), 744-53
    DOI 10.1093/ehjci/jew027, PubMed 27002140

    Publications 2015

    Bethke A, Halvorsen S, Bøhmer E, Abdelnoor M, Arnesen H, Hoffmann P (2015)
    Myocardial perfusion grade predicts final infarct size and left ventricular function in patients with ST-elevation myocardial infarction treated with a pharmaco-invasive strategy (thrombolysis and early angioplasty)
    EuroIntervention, 11 (5), 518-24
    DOI 10.4244/EIJY15M04_02, PubMed 25868877

    Limalanathan S, Eritsland J, Kløw NE, Abdelnoor M, Hoffmann P, Andersen GØ (2015)
    Influence of ischemic postconditioning on myocardial dysfunction measured by speckle tracking echocardiography in patients with ST-elevation myocardial infarction
    Int J Cardiol, 187, 459-61
    DOI 10.1016/j.ijcard.2015.03.192, PubMed 25846653

    Publications 2014

    Fadl Elmula FE, Hoffmann P, Larstorp AC, Fossum E, Brekke M, Kjeldsen SE, Gjønnæss E, Hjørnholm U, Kjaer VN, Rostrup M, Os I, Stenehjem A, Høieggen A (2014)
    Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertension
    Hypertension, 63 (5), 991-9
    DOI 10.1161/HYPERTENSIONAHA.114.03246, PubMed 24591332

    Helseth R, Solheim S, Opstad T, Hoffmann P, Arnesen H, Seljeflot I (2014)
    The time profile of Pentraxin 3 in patients with acute ST-elevation myocardial infarction and stable angina pectoris undergoing percutaneous coronary intervention
    Mediators Inflamm, 2014, 608414
    DOI 10.1155/2014/608414, PubMed 24737925

    Kjeldsen SE, Sørensen H, Fadl Elmula FE, Brekke M, Gjønnæss E, Hjørnholm U, Kjære VN, Rostrup M, Fossum E, Os I, Stenehjem A, Høieggen A, Hoffmann P (2014)
    [Re: Renal sympathetic denervation in treatment-resistant hypertension]
    Tidsskr Nor Laegeforen, 134 (15), 1449-50
    DOI 10.4045/tidsskr.14.0931, PubMed 25138398

    Limalanathan S, Andersen GØ, Kløw NE, Abdelnoor M, Hoffmann P, Eritsland J (2014)
    Effect of ischemic postconditioning on infarct size in patients with ST-elevation myocardial infarction treated by primary PCI results of the POSTEMI (POstconditioning in ST-Elevation Myocardial Infarction) randomized trial
    J Am Heart Assoc, 3 (2), e000679
    DOI 10.1161/JAHA.113.000679, PubMed 24760962

    Mariampillai JE, Fadl Elmula FE, Hoffmann P, Sørensen H, Høieggen A, Kjeldsen SE (2014)
    [Questionable efficacy of renal denervation]
    Tidsskr Nor Laegeforen, 134 (17), 1643-4
    DOI 10.4045/tidsskr.14.0900, PubMed 25223668

    Njerve IU, Solheim S, Lunde K, Hoffmann P, Arnesen H, Seljeflot I (2014)
    Fractalkine levels are elevated early after PCI-treated ST-elevation myocardial infarction; no influence of autologous bone marrow derived stem cell injection
    Cytokine, 69 (1), 131-5
    DOI 10.1016/j.cyto.2014.05.022, PubMed 24930044

    Sørensen H, Fadl Elmula FE, Kjeldsen SE, Brekke M, Gjønnæss E, Hjørnholm U, Kjær VN, Rostrup M, Fossum E, Os I, Stenehjem A, Høieggen A, Hoffmann P (2014)
    [Renal sympathetic denervation in treatment-resistant hypertension]
    Tidsskr Nor Laegeforen, 134 (1), 32-6
    DOI 10.4045/tidsskr.13.0276, PubMed 24429753

    Publications 2013

    Fadl Elmula FE, Hoffmann P, Fossum E, Brekke M, Gjønnæss E, Hjørnholm U, Kjær VN, Rostrup M, Kjeldsen SE, Os I, Stenehjem AE, Høieggen A (2013)
    Renal sympathetic denervation in patients with treatment-resistant hypertension after witnessed intake of medication before qualifying ambulatory blood pressure
    Hypertension, 62 (3), 526-32
    DOI 10.1161/HYPERTENSIONAHA.113.01452, PubMed 23836798

    Gulati G, Heck SL, Ree AH, Gravdehaug B, Røsjø H, Steine K, Bratland Å, Hoffmann P, Geisler J, Omland T (2013)
    [Cardioprotective treatment during adjuvant cancer therapy]
    Tidsskr Nor Laegeforen, 133 (17), 1832-6
    DOI 10.4045/tidsskr.12.1514, PubMed 24042297

    Limalanathan S, Eritsland J, Andersen GØ, Kløw NE, Abdelnoor M, Hoffmann P (2013)
    Myocardial salvage is reduced in primary PCI-treated STEMI patients with microvascular obstruction, demonstrated by early and late CMR
    PLoS One, 8 (8), e71780
    DOI 10.1371/journal.pone.0071780, PubMed 23977143

    Publications 2012

    Heck SL, Gulati G, Ree AH, Schulz-Menger J, Gravdehaug B, Røsjø H, Steine K, Bratland A, Hoffmann P, Geisler J, Omland T (2012)
    Rationale and design of the prevention of cardiac dysfunction during an Adjuvant Breast Cancer Therapy (PRADA) Trial
    Cardiology, 123 (4), 240-7
    DOI 10.1159/000343622, PubMed 23207160

    Publications 2011

    Grøgaard HK, Solheim S, Landsverk KS, Seljeflot I, Hoffmann P, Arnesen H, Ilebekk A (2011)
    Circulating CD34⁺ progenitor cells and growth factors in patients treated with PCI for acute myocardial infarction or stable angina pectoris
    Scand J Clin Lab Invest, 71 (4), 322-9
    DOI 10.3109/00365513.2011.565367, PubMed 21463159

    Mistry N, Abdelnoor M, Seljeflot I, Hoffmann P, Bøhmer E, Bjørnerheim R, Kjeldsen SE, Halvorsen S (2011)
    Amino-terminal pro-B-type natriuretic peptide (NT-proBNP) levels 3 months after myocardial infarction are more strongly associated with magnetic resonance-determined ejection fraction than NTproBNP levels in the acute phase
    J Card Fail, 17 (6), 479-86
    DOI 10.1016/j.cardfail.2011.02.006, PubMed 21624736

    Mistry N, Beitnes JO, Halvorsen S, Abdelnoor M, Hoffmann P, Kjeldsen SE, Smith G, Aakhus S, Bjørnerheim R (2011)
    Assessment of left ventricular function in ST-elevation myocardial infarction by global longitudinal strain: a comparison with ejection fraction, infarct size, and wall motion score index measured by non-invasive imaging modalities
    Eur J Echocardiogr, 12 (9), 678-83
    DOI 10.1093/ejechocard/jer113, PubMed 21810829

    Stensaeth KH, Hoffmann P, Fossum E, Mangschau A, Sandvik L, Klow NE (2011)
    Cardiac magnetic resonance visualizes acute and chronic myocardial injuries in myocarditis
    Int J Cardiovasc Imaging, 28 (2), 327-35
    DOI 10.1007/s10554-011-9812-7, PubMed 21347598

    Publications 2010

    Bøhmer E, Seljeflot I, Arnesen H, Hoffmann P, Abdelnoor M, Halvorsen S (2010)
    The association between metabolic syndrome and infarct size in patients with acute myocardial infarction
    Scand J Clin Lab Invest, 70 (4), 287-93
    DOI 10.3109/00365513.2010.481819, PubMed 20429699

    Limalanathan S, Andersen GØ, Hoffmann P, Kløw NE, Abdelnoor M, Eritsland J (2010)
    Rationale and design of the POSTEMI (postconditioning in ST-elevation myocardial infarction) study
    Cardiology, 116 (2), 103-9
    DOI 10.1159/000316965, PubMed 20588018

    Mistry N, Bøhmer E, Hoffmann P, Müller C, Bjørnerheim R, Kjeldsen SE, Halvorsen S (2010)
    Left ventricular function in acute myocardial infarction treated with thrombolysis followed by early versus late invasive strategy
    Am Heart J, 160 (1), 73-9
    DOI 10.1016/j.ahj.2010.04.011, PubMed 20598975

    Mistry N, Halvorsen S, Hoffmann P, Müller C, Bøhmer E, Kjeldsen SE, Bjørnerheim R (2010)
    Assessment of left ventricular function with magnetic resonance imaging vs. echocardiography, contrast echocardiography, and single-photon emission computed tomography in patients with recent ST-elevation myocardial infarction
    Eur J Echocardiogr, 11 (9), 793-800
    DOI 10.1093/ejechocard/jeq069, PubMed 20525984

    Stensæth KH, Fossum E, Hoffmann P, Mangschau A, Skretteberg PT, Kløw NE (2010)
    Takotsubo cardiomyopathy in acute coronary syndrome; clinical features and contribution of cardiac magnetic resonance during the acute and convalescent phase
    Scand Cardiovasc J, 45 (2), 77-85
    DOI 10.3109/14017431.2010.531140, PubMed 20979536

    Publications 2009

    Bøhmer E, Hoffmann P, Abdelnoor M, Arnesen H, Halvorsen S (2009)
    Efficacy and safety of immediate angioplasty versus ischemia-guided management after thrombolysis in acute myocardial infarction in areas with very long transfer distances results of the NORDISTEMI (NORwegian study on DIstrict treatment of ST-elevation myocardial infarction)
    J Am Coll Cardiol, 55 (2), 102-10
    DOI 10.1016/j.jacc.2009.08.007, PubMed 19747792

    Bøhmer E, Hoffmann P, Abdelnoor M, Seljeflot I, Halvorsen S (2009)
    Troponin T concentration 3 days after acute ST-elevation myocardial infarction predicts infarct size and cardiac function at 3 months
    Cardiology, 113 (3), 207-12
    DOI 10.1159/000201991, PubMed 19218804

    Furenes EB, Arnesen H, Solheim S, Grøgaard HK, Hoffmann P, Seljeflot I (2009)
    The profile of circulating metalloproteinases after PCI in patients with acute myocardial infarction or stable angina
    Thromb Res, 124 (5), 560-4
    DOI 10.1016/j.thromres.2009.04.001, PubMed 19410278

    Publications 2007

    Bøhmer E, Arnesen H, Abdelnoor M, Mangschau A, Hoffmann P, Halvorsen S (2007)
    The NORwegian study on DIstrict treatment of ST-elevation myocardial infarction (NORDISTEMI)
    Scand Cardiovasc J, 41 (1), 32-8
    DOI 10.1080/14017430601153472, PubMed 17365975

    Publications 2006

    Hoffmann P, Halvorsen S, Stensaeth KH, Brekke M, Müller C, Anker GO, Abdelnoor M, Kløw NE (2006)
    Myocardial perfusion in ST-elevation myocardial infarction treated successfully with primary angioplasty
    Scand Cardiovasc J, 40 (2), 96-104
    DOI 10.1080/14017430600628144, PubMed 16608779

    Publications 2004

    Undseth RM, Kløw NE, Hoffmann P (2004)
    [Treatment of pseudoaneurysms after vascular interventions]
    Tidsskr Nor Laegeforen, 124 (10), 1384-6
    PubMed 15195176

    Page visits: 2491